Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision update from v3.3.1 to v3.3.2 with no changes to the study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:14.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updates detected: added Revision: v3.3.1 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T13:19:41.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice regarding potential delays in updates; the page now omits that disclaimer.
    Difference
    0.1%
    Check dated 2025-11-17T06:27:28.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No substantive changes detected; observed updates appear limited to minor UI text tweaks and the page's last updated timestamp, with core study content, eligibility criteria, primary outcomes, and locations remaining the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:10:29.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    1%
    Check dated 2025-10-05T09:34:17.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page shifts from detailed cancer histology terms to broader immunology-related topics and updates to a new revision (v3.1.0), removing several cancer-specific classifications (v3.0.2).
    Difference
    2%
    Check dated 2025-09-28T03:06:42.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.